All products / DC7997
CAT. NO. DC7997
ACTB-1003
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $700 USDRequest a quote → |
| 250 mg | $1,200 USDRequest a quote → |
| 1 g | $2,500 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
ACTB-1003 is an oral kinase inhibitor with IC50s of 6, 2 and 4 nM for FGFR1, VEGFR2 and Tie-2.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC7997 |
|---|---|
| Product name | ACTB-1003 |
| CAS | 939805-30-8 |
| Molecular formula | C27H26F5N7O3 |
| Molecular weight | 591.5325 |
| Purity | >98% |
| SMILES | FC1=C(C([H])=C([H])C(=C1[H])C1=C2C(N([H])[H])=NC([H])=NN2C(=C1C([H])([H])OC([H])([H])[H])C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H])N([H])C(N([H])C1=C(C([H])=C([H])C(C(F)(F)F)=C1[H])F)=O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — ACTB-1003 (DC7997)Source references
[1]. Patel K, et al. ACTB-1003: An oral kinase inhibitor targeting cancer mutations (FGFR), angiogenesis (VEGFR2, TEK), and induction of apoptosis (RSK and p70S6K). Journal of Clinical Oncology 28, no. 15 DOI: 10.1200/jco.2010.28.15_suppl.e13665
